Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Willis Towers Watson (WTW) · oqro.io/stocks/WTW · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Since the trade +31.1% · S&P 500 −6.0% · to Nov 20
Bought at the 52-week low, RSI 26, 20% under its 200-day average, 33 points behind the S&P 500 over 3 months
Willis Towers Watson's President of Risk & Broking paid $499K out of pocket for Willis Towers Watson shares. 1 other person at Willis Towers Watson bought some too, in the same month. Shares held went up 9% with this purchase.
Traded Mar 3, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −2.8% · S&P 500 +18.2% · to Nov 20
Willis Towers Watson's Pres.-Health, Wealth & Career sold $547K of Willis Towers Watson shares. The filing does not indicate a pre-arranged trading plan.
Traded Feb 28, 2025 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −2.5% · S&P 500 +16.1% · to Nov 20
Willis Towers Watson's Pres.-Health, Wealth & Career sold $1.14M of Willis Towers Watson shares. The filing does not indicate a pre-arranged trading plan.
The CEO of Willis Towers Watson paid $510K out of pocket for Willis Towers Watson shares. 1 other person at Willis Towers Watson bought some too, in the same month.
Willis Towers Watson's President of Risk & Broking paid $997K out of pocket for Willis Towers Watson shares. 1 other person at Willis Towers Watson bought some too, in the same month. Shares held went up 22% with this purchase.
A Willis Towers Watson director paid $67K out of pocket for Willis Towers Watson shares. 1 other person at Willis Towers Watson bought some too, in the same month. Shares held went up 11% with this purchase.
4 open-market purchases and 3 open-market sales by insiders of WTW between Jan 4, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 29, 2026. The data provider lists the next release for Feb 1, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Andrew Jay Krasner, Chief Financial Officer, Nov 13, 2026, about $515K. Sold 15 days after the company's previous earnings release on 2026-10-29Form 4
Alexis Faber, Chief Operating Officer, Aug 10, 2026, about $250K. Sold 11 days after the company's previous earnings release on 2026-07-30Form 4
Lucy Clarke, President of Risk & Broking, May 6, 2026, about $499K. Bought 6 days after the company's previous earnings release on 2026-04-30Form 4
Carl Aaron Hess, Chief Executive Officer, May 4, 2026, about $510K. Bought 4 days after the company's previous earnings release on 2026-04-30Form 4
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
Matthew Furman, General Counsel, Mar 3, 2026, about $912K. Sold 28 days after the company's previous earnings release on 2026-02-03